Search
for
Sort by
Research 30 of 793
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Replicative stress, stem cells and aging
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Skin Biology and Ageing
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Differences in cell subsets between sun-exposed and unexposed skin: preliminary single-cell sequencing and biological analysis from a single case
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes
- DNA Damage, Checkpoint Responses, and Cell Cycle Control in Aging Stem Cells
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- ATP-competitive mTOR kinase inhibitors delay plant growth by triggering early differentiation of meristematic cells but no developmental patterning change
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Embryologic layers in dermatology: Developmental checkpoint disorders, diagnostic insight, and regenerative futures
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Pyruvate Kinase M2 Role in Cardiovascular Repair
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Expression Profiles of Tyrosine Kinases in Cultured Follicular Papilla Cells Versus Dermal Fibroblasts
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- The role of lymphocytes in the development and treatment of alopecia areata
- Cyclin-dependent kinase inhibitors, p21waf1/cip1 and p27kip1, are expressed site- and hair cycle-dependently in rat hair follicles
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Novel small molecules downregulate CDK1 expression and inhibit Wnt/β-catenin signaling in cutaneous squamous cell carcinoma by targeting its distinct tumor-specific cellular landscape
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata